Main content
'Not too late to review cost' of breast cancer drug Kadcyla
The NHS has rejected a drug that can extend lives of women with breast cancer because it is 鈥榯oo expensive鈥�. Jennifer Cozzone head of Health Economics and Pricing at Roche and Mia Rosenblatt from Breast Cancer Campaign discuss.
Duration:
This clip is from
Featured in...
![]()
Health clips
Listen to a selection of clips from recent and upcoming programmes.
More clips from Today
-
![]()
Lost letter from pope could unravel Battle of Hastings history
Duration: 04:04
-
![]()
The woman who tried to warn police about double murderer
Duration: 02:59
-
![]()
PM wants plan to keep Harper killers in prsion
Duration: 06:14
-
![]()
Man's 1,700-mile round trip to save rare phone box
Duration: 03:17
